Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

932
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
932
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

587
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
587
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

236
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
236
Randomized Experiments01:13

Randomized Experiments

8.5K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.5K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

65
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
65
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

350
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
350

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do studies of interventions to improve laypeople's critical thinking about health choices assess potential harms? A systematic review.

BMJ open·2026
Same author

Classroom air purifiers for reducing school absence: study protocol for a pragmatic, cluster-randomised, parallel, two-arm, group sequential superiority trial.

BMJ open·2025
Same author

Development of a framework of potential adverse effects of interventions to improve critical thinking about health choices: A mixed methods study.

F1000Research·2025
Same author

Participants' experiences of potential adverse effects of an intervention to improve critical thinking about health choices: a qualitative cross-trial process evaluation in Kenya, Rwanda and Uganda.

BMJ open·2025
Same author

Single-Arm Trials Can Provide Randomized Real-World Evidence: The Random Invitation Single-Arm Trial Design.

Annals of internal medicine·2025
Same author

Why were so few randomized trials of public health and social measures conducted during the COVID-19 pandemic? The Norwegian experience.

Trials·2024

Related Experiment Video

Updated: Nov 11, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

870

COVID-19: underpowered randomised trials, or no randomised trials?

Atle Fretheim1,2

  • 1Centre of Informed Health Choices, Norwegian Institute of Public Health, Oslo, Norway. atle.fretheim@fhi.no.

Trials
|March 30, 2021
PubMed
Summary

Conducting public health randomized trials, like those for COVID-19 face mask use, faces challenges with large sample sizes. Underpowered trials contribute valuable evidence when large trials are infeasible.

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.8K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.9K

Related Experiment Videos

Last Updated: Nov 11, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

870
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.8K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.9K

Area of Science:

  • Public Health Research
  • Epidemiology
  • Clinical Trials

Background:

  • Randomized trials for public health interventions, such as face mask efficacy during COVID-19, often require impractically large sample sizes.
  • This sample size requirement presents a significant barrier to conducting rigorous research in real-world public health settings.

Discussion:

  • The necessity of large sample sizes can lead to a dichotomy where the choice is between underpowered studies or no studies at all.
  • Underpowered trials should not be dismissed but recognized as valuable components of a broader evidence base.
  • Systematic reviews are crucial for synthesizing findings from studies of varying sizes and designs.

Key Insights:

  • Overemphasis on achieving statistically perfect sample sizes can impede scientific progress in public health.
  • Even underpowered studies contribute to the collective understanding when integrated into comprehensive systematic reviews.
  • Alternative trial designs and meta-analytic approaches are essential for advancing public health knowledge.

Outlook:

  • Future public health research should embrace a more pragmatic approach to trial design and evidence synthesis.
  • Focus should shift towards maximizing the utility of all available data, including from smaller or underpowered studies.
  • Developing innovative methodologies for evidence aggregation will be key to overcoming sample size limitations in public health interventions.